| Christopher Atwell, MD | |
|
Banner Desert Medical Center Attn: Hospitalists, 1400 S Dobson Rd, Mesa, AZ 85202 | |
| (480) 412-6788 | |
| (480) 412-6848 |
| Full Name | Christopher Atwell |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | Banner Desert Medical Center Attn: Hospitalists, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194139857 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Atwell, MD Banner Desert Medical Center Attn: Hospitalists, 1400 S Dobson Rd, Mesa, AZ 85202 Ph: (480) 412-6788 | Christopher Atwell, MD Banner Desert Medical Center Attn: Hospitalists, 1400 S Dobson Rd, Mesa, AZ 85202 Ph: (480) 412-6788 |
News Archive
TSO3 Inc., an innovator in low temperature sterilization technology for medical devices in healthcare settings, through the use of ozone (a cost effective, safe and eco-friendly method) today announced that it has filed a patent application in the United States seeking protection in that market as well as preserving rights in many other countries of recent innovations made to its sterilization systems, which enable both significantly faster and gentler cycles.
Intarcia Therapeutics, Inc. today announced positive top-line results from its 52-week Phase 3 FREEDOM-2 clinical trial to determine the comparative efficacy of the company's late-stage investigational candidate ITCA 650 to Merck's Januvia in reducing HbA1c in patients with type 2 diabetes following a year of treatment.
China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced record sales for its first quarter ended March 31, 2010. The Company's quarterly report on Form 10-Q was filed on May 17, 2010 with the United States Securities and Exchange Commission.
Scientists who examined more than 10,000 chemical compounds during the last year in search of potential new drugs for a group of untreatable brain diseases, are reporting that one substance shows unusual promise.
The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone, a rare and usually non-cancerous tumor.
› Verified 9 days ago
Gregg Alan Smith, D.O. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1042 N Higley Rd, Suite 102-602, Mesa, AZ 85205 Phone: 480-242-6297 Fax: 480-699-3129 | |
Dr. Fayz Yar Khan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 10238 E Hampton Ave, Mesa, AZ 85209 Phone: 480-354-6463 | |
Dr. Marwan Mohammed Oleiwi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Banner Baywood Medical Center, Mesa, AZ 85206 Phone: 480-321-3900 Fax: 480-321-3840 | |
Dr. Pawan A Dhawan, MBBS Hospitalist Medicare: Medicare Enrolled Practice Location: Bdmc/attn: Bmg Hospitalists, 1400 S Dobson Road, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Katelyn Rheault, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Mesa, AZ 85206 Phone: 602-839-3644 | |
Dr. Lloyd Centino, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Banner Desert Medical Center Attn Hospitalist, 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Ritesh Kanotra, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6644 E Baywood Ave, Banner Baywood Medical Center, Mesa, AZ 85206 Phone: 480-321-3900 Fax: 480-321-3840 |